Alcohol Pharmacogenetics in Mexican Americans
Alcohol Pharmacogenetics in Mexican Americans
批准号:
7854437
负责人:
Yu-Jui Yvonne Wan
金额:
$8.05万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2010-05-31
关键词:
AODR mortalityAccountingAddictive BehaviorAfrican AmericanAge of OnsetAlcohol abuseAlcohol consumptionAlcohol dehydrogenaseAlcohol dependenceAlcoholic beverage heavy drinkerAlcoholismAlcoholsAllelesBehaviorBehavioralCYP2E1 geneCaucasiansCaucasoid RaceCensusesClinicalCytochromes c2DRD2 geneDataDevelopmentDopamine ReceptorEmotionalEthanol MetabolismEthnic groupFundingGene FrequencyGenesGeneticGenetic PolymorphismGenotypeGrantHaplotypesHealthHeavy DrinkingHispanicsKnowledgeLinkMethodsMexicanMexican AmericansMinorityMinority GroupsMorbidity - disease ratePatternPharmacogeneticsPopulationRelative (related person)ResearchResearch InfrastructureResearch PersonnelRiskRisk FactorsRoleSeveritiesSmokerSmokingStructureTestingTimeUnited StatesVariantWomanaddictionalcohol related problemaldehyde dehydrogenasesbinge drinkingclinical phenotypedrinkingearly onsetethnic differenceethnic minority populationexperiencegenetic associationgenetic profilinggenetic risk factorhigh riskknowledge basemalemennon-alcoholicproblem drinkerprogramsserotonin transporter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Representing one of the fastest growing ethnic groups in the United States, Hispanics accounted for 12% of the nation's population by March 2000, and suffer from higher rates of alcohol related problems as compared with those from other ethnic backgrounds (e.g., Caucasians and African Americans). This notwithstanding, genetic factors that might contribute to such risks remain poorly understood. Building upon the research infrastructure that has been established, this competitive continuation application will systematically explore and examine genetic mechanisms for alcoholism in Mexican Americans. This ongoing research program has started to identify unique genetic patterns that might be in part responsible for the heightened risk for alcoholism and alcohol associated health problems in this population. These include (1) extremely low allele frequency for both ALDH2*2 (aldehyde dehydrogenase) and ADH2*2 (alcohol dehydrogenase); (2) a relatively high rate of ADH3*2 and CYP2E1 c2 (cytochrome P4502E1) alleles; (3) association of ADH3*2, ADH2*1, DRD2 (dopamine receptor -141C Del/Ins) and serotonin transporter gene-linked polymorphic region (5-HTTLPR) with alcoholism; (4) a strong association of ADH3*2 and ADH2*1 alleles with binge drinking; and (5) association of the DRD2 Taq1 A and 1B alleles with early age of onset for drinking. In this new funding cycle, we plan to further pursue and clarify the meaning of these findings. Specifically, we will (1) expand our study to include Mexican American women with alcohol problems; (2) further examine the role of these polymorphisms, as well as their potential interactions, in relation to risks for alcoholism in Mexican American populations; (3) examine the role of these risks in relationship with the severity of alcoholism i.e. binge drinking and early onset of drinking; (4) characterize and determine the haplotype of DRD2 in association with drinking in Mexican Americans, and assess the relative advantage of haplotype vs. allelic analysis in delineating risk factors contributory to the development of alcoholism. This study will be the first to systematically examine how genetic factors modulate alcohol dependence and abuse in Mexican Americans. Results derived from such a study should not only provide for a better understanding of alcohol use and abuse among Mexican Americans, but also contribute towards a knowledge base regarding ethnic differences in alcohol pharmacogenetics and mechanisms that might be responsible for the high rate of alcoholism in this minority population.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2165/00129785-200404060-00006
发表时间:
2004-01-01
期刊:
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice
影响因子:
--
作者:
[Luo, Huai-Rong, Aloumanis, Vasileios, Wan, Yu-Jui Yvonne]
通讯作者:
Wan, Yu-Jui Yvonne
DOI:
10.3748/wjg.v18.i37.5276
发表时间:
2012-10
期刊:
World journal of gastroenterology
影响因子:
4.3
作者:
[Yaming Wei;Yanlei Du;Y. Nie;Yu-yuan Li;Y. Wan]
通讯作者:
Yaming Wei;Yanlei Du;Y. Nie;Yu-yuan Li;Y. Wan
Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene.
人CYP7A1基因的连锁不平衡块,单倍型结构和HTSNP。
DOI:
10.1186/1471-2156-7-29
发表时间:
2006-05-18
期刊:
BMC GENETICS
影响因子:
2.9
作者:
[Nakamoto, Kaori, Wang, Shuang, Jenison, Robert D., Guo, Grace L., Klaassen, Curtis D., Wan, Yu-Jui Yvonne, Zhong, Xiao-bo]
通讯作者:
Zhong, Xiao-bo
DOI:
10.1016/j.psychres.2010.02.021
发表时间:
2010-05-30
期刊:
PSYCHIATRY RESEARCH
影响因子:
11.3
作者:
[Du, Yanlei, Yang, Min, Yeh, Hung-Wen, Wan, Yu-Jui Yvonne]
通讯作者:
Wan, Yu-Jui Yvonne
Identification of CYP2D6 impaired functional alleles in Mexican Americans.
墨西哥裔美国人中 CYP2D6 功能受损等位基因的鉴定。
DOI:
10.1007/s00228-005-0044-4
发表时间:
2005
期刊:
European journal of clinical pharmacology
影响因子:
2.9
作者:
[Luo,Huai-Rong, Gaedigk,Andrea, Aloumanis,Vasileios, Wan,Yu-JuiYvonne]
通讯作者:
Wan,Yu-JuiYvonne
共 10 条
Liver Cancer Therapy by MiR-22 and Its Inducers
-
批准号:10556373
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2018
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Liver Cancer Therapy by MiR-22 and Its Inducers
-
批准号:10330455
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2018
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Liver Cancer Therapy by MiR-22 and Its Inducers
-
批准号:10094055
-
项目类别:
-
资助金额:$43.65万
-
财政年份:2018
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Retinoic Acid, Its Receptors, and the Liver
-
批准号:8529067
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: MOLECULAR BIOLOGY CORE
-
批准号:8360780
-
项目类别:
-
资助金额:$6.02万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Retinoic Acid, Its Receptors, and the Liver
-
批准号:8296548
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Retinoic Acid, Its Receptors, and the Liver
-
批准号:8465227
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Retinoic Acid, Its Receptors, and the Liver
-
批准号:8662762
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Retinoic Acid, Its Receptors, and the Liver
-
批准号:8205418
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: MOLECULAR BIOLOGY CORE
-
批准号:8167659
-
项目类别:
-
资助金额:$5.64万
-
财政年份:2010
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: CORE B: MOLECULAR BIOLOGY CORE
-
批准号:7959503
-
项目类别:
-
资助金额:$6.2万
-
财政年份:2009
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: CORE B: MOLECULAR BIOLOGY CORE
-
批准号:7720180
-
项目类别:
-
资助金额:$5.68万
-
财政年份:2008
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
COBRE: U OF KANSAS MEDICAL CTR: CORE B: MOLECULAR BIOLOGY CORE
-
批准号:7610768
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2007
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
Alcohol Pharmacogenetics in Mexican-Americans
-
批准号:7042097
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2003
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
ALCOHOL PHARMACOGENETICS IN MEXICAN AMERICANS
-
批准号:6553724
-
项目类别:
-
资助金额:$4.58万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
SAMe, RXRalpha-mediated Pathways and ALD
-
批准号:6593676
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
SAMe, RXRalpha-mediated Pathways and ALD
-
批准号:6929340
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
SAMe, RXRalpha-mediated Pathways and ALD
-
批准号:6784107
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
SAMe, RXRalpha-mediated Pathways and ALD
-
批准号:6663814
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
SAMe, RXRalpha-mediated Pathways and ALD
-
批准号:6859130
-
项目类别:
-
资助金额:$26.94万
-
财政年份:2002
-
负责人:Yu-Jui Yvonne Wan
-
依托单位:
海外基金